Skip to content
healthcare.dev

ADSTILADRIN

NDC 55566-1050, nadofaragene firadenovec-vncg, suspension, from Ferring Pharmaceuticals Inc..

Product NDC
55566-1050
Status
Listed
Labeler
Ferring Pharmaceuticals Inc.
Dosage form
SUSPENSION
Route
INTRAVESICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125700
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1050 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NADOFARAGENE FIRADENOVEC300000000000 {VP}/mL
Package NDCNDC-11Package
55566-1050-1555661050014 VIAL in 1 CARTON (55566-1050-1) / 20 mL in 1 VIAL (55566-1050-0)
55566-1050-25556610500220 mL in 1 VIAL (55566-1050-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5ca20ed4-da4f-463c-ac2a-ccd6ab3774fa
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55566-1050

Use it

Look up 55566-1050 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55566-1050 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55566-1050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.